CarbGeM Inc. logo — Japan-based startup, Combating Antibiotic-Resistant Bacteria...

CarbGeM Inc.

Japan-based startup, Combating Antibiotic-Resistant Bacteria by next Generation of Medical Device.

Founded 2021 Japan Japan 14 employees AI, Biopharma +2

General Information

Company Name CarbGeM Inc.
Founded Year 2021
Location Japan Japan
Employees 14
Industries AI, Biopharma, Health Care +1
Social

BounceWatch is an independent company data service, not affiliated with CarbGeM Inc.. To contact CarbGeM Inc., visit carbgem.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About CarbGeM Inc.

CarbGeM Inc. is a Japan-based startup dedicated to combating antibiotic-resistant bacteria with their next-generation medical device. Their flagship product, BiTTE, is an application designed to estimate bacterial species in bacterial infections and provide support in selecting appropriate antibiotics. Utilizing AI image recognition technology for Gram stain images, BiTTE ensures highly accurate bacterial species estimation and guides the selection of antibiotics by connecting with antibiograms. In addition to this cutting-edge application, CarbGeM Inc. offers Point of Care Gram Staining (PoCGS), a small and affordable medical device designed for installation in emergency outpatient departments, intensive care units, and community clinics. PoCGS allows for quick staining of patient samples on a slide glass, with the stained samples being completed in just 10 minutes. The device's operation panel enables the adjustment of sample types, reagent titration amount, staining time, and other relevant parameters. Founded in 2021, CarbGeM Inc. operates within the AI, Biopharma, Health Care, and Medical Devices industries. As for their current funding status, there is no public information available regarding last investment or investors. This innovative startup is poised to make meaningful contributions in the fight against antibiotic resistance and the improvement of healthcare outcomes.

Taxonomy: Medical Device Innovation, Antibiotic Resistance Solutions, Point of Care Diagnostics, AI Technology in Healthcare, Gram Staining Technology, Infectious Disease Management, Healthcare Innovation, Medical Imaging Analysis, Antibiotic Selection Support System, Biotechnology Startups

No funding data available for CarbGeM Inc. yet.

CarbGeM Inc. Alternatives & Competitors

CarbGeM Inc. vs

Avails Medical, Inc. - Affordable & Rapid Antibiotic Susceptibility Testing for clinical laboratorie...

Grant
51 employees
Health Care, Medical Devices
CarbGeM Inc. vs

Confirmatory precision diagnostics for tuberculosis (MDR/XDR-TB) within 3 h even at resource-limited...

Series A
27 employees
Biotechnology, Health Care
CarbGeM Inc. vs
Aksense
Aksense Turkey

Point-of-Care Testing for Infectious Diseases

Seed
4 employees
Health Care, Medical Devices

FAQ About CarbGeM Inc.

Japan-based startup, Combating Antibiotic-Resistant Bacteria by next Generation of Medical Device.
CarbGeM Inc. was founded in 2021.
CarbGeM Inc. is headquartered in Japan.
CarbGeM Inc. operates in AI, Biopharma, Health Care and Medical Devices. Its work centres on Medical Device Innovation, Antibiotic Resistance Solutions, Point of Care Diagnostics and AI Technology in Healthcare.
CarbGeM Inc. has approximately 14 employees.
Top alternatives and competitors to CarbGeM Inc. include Avails Medical, Inc., EMPE Diagnostics, Aksense, Astek Diagnostics, ENDRA Life Sciences (Nasdaq: NDRA). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CarbGeM Inc. and Avails Medical, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CarbGeM Inc., https://bouncewatch.com/company/carbgem-inc, updated 7 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes